Cell Res 31(2):107125 Tharayil SP, Shukla P (2025) Connecting the dots: mitochondrial dysfunction, PCOS, and insulin resistance-insights and therapeutic advances
SLU-PP-332 is a synthetic small-molecule pan-ERR agonist developed in the Thomas Burris lab
In anti-aging, they stimulate collagen and elastin production, enhance skin hydration, and promote cellular repair, leading to firmer, more youthful skin and improved overall wellness
Cagrilintide is the first next-generation amylin analogue to be tested at scale
It depends on disciplined execution: validated processes, environmental control, contamination prevention, supplier qualification, batch documentation, deviation management, and a culture where data drives every decision
Next-generation therapies, which include combinations of GLP-1 drugs and other peptides, are being studied for their potential to better preserve muscle and bone compared with GLP-1 drugs alone